.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
India's largest standalone health insurer, Star Health and Allied Insurance, is launching a new product named Value Plus. This policy delivers affordable health insurance directly to tier-2, tier-3, and tier-4 cities across the country. Additionally, the new plan offers premiums that are approximately 20% lower than the company's existing products in these regions. Therefore, this strategic move aims to improve insurance penetration in markets where cost has traditionally been a significant barrier.
Anand Roy, the Managing Director and CEO of Star Health, emphasized that cost is a major hurdle in smaller towns. Consumer surveys show that high premiums frequently deter families from purchasing coverage. Consequently, the company designed this new product to retain essential mainstream features while keeping the prices lower. Specifically, the annual premiums for Value Plus will range between ₹15,000 and ₹16,000. Furthermore, the insurer expects this product to contribute around 10% of its future revenue.
Interestingly, the insurer decided to exclude metro cities from this budget-friendly offering. Healthcare inflation and hospital claims costs continue to rise significantly in metropolitan areas. In contrast, non-metro markets demonstrate greater structural profitability. For instance, loss ratios in smaller cities are currently running 4 to 5 percentage points lower than the company's overall average of 69%. Consequently, the lower operating costs in these regions allow the company to offer cheaper premiums without compromising on coverage quality.
The launch aligns with increasing insurance demand following the Indian government's GST waiver on health insurance premiums. This policy change has successfully driven higher renewals and improved persistency rates. Moreover, Star Health is expanding its distribution channel by appointing nearly one lakh new agents, with 80% of them operating in tier-2, tier-3, and tier-4 areas. To complement this, the insurer is rolling out \"Pratham,\" a preferred hospital network initiative. This program aims to minimize discharge delays and enhance patient satisfaction through direct hospital collaborations.
Q1: What is the new product launched by Star Health and Allied Insurance for non-metro cities?
Star Health has introduced an affordable health plan called Value Plus, targeting tier-2, tier-3, and tier-4 markets. This product offers premiums that are roughly 20% lower than existing policies while maintaining standard coverage features.
Q2: Why are metro cities excluded from this cheaper health insurance plan?
Metro cities face elevated healthcare inflation and higher hospital claim costs. In contrast, smaller cities have lower loss ratios, making them structurally more profitable and enabling lower premiums.
Q3: What is the \"Pratham\" initiative launched by Star Health?
Pratham is a preferred hospital network initiative designed by Star Health to improve the overall customer experience, minimize cashless discharge delays, and foster closer collaboration with select hospitals.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Star Health launches Value Plus, a 20% cheaper health cover for tier-2 and tier-3 cities in India to address affordability issues and boost penetration....
2 months ago
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
